CHICAGO, Nov. 18, 2022 (GLOBE NEWSWIRE) -- "Kidney Disease Market" is the title of a new report from Data Bridge Market Research. Key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive environment are all dissected in detail in the research. To understand the market in-depth, a Kidney Disease market research report is the perfect solution. With the specific base year and the historic year, estimations and calculations are performed in the report. This global market research report studies the market at regional and global levels by considering major geographical areas. This Kidney Disease report is generated with the combination of the best industry insight, practical solutions, talent solutions, and the latest technology. The analysis and forecasting of market data using the best statistical and coherent models, market share analysis, and key trend analysis are the major accomplishing factors in this market report.
Data Bridge Market Research analyses a growth rate in the global kidney disease market in the forecast period 2022-2029. The expected CAGR of the global kidney disease market tends to be around 5.50% in the mentioned forecast period. The market was valued at USD 96.72 billion in 2021, and it would grow up to USD 148.43 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Gain Access to Sample PDF of the Kidney Disease Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-kidney-disease-market
Kidney disease damages the nephron, unable for the kidney to function to remove the waste product from the body. The disease can cause other severe problems such as hypertension, kidney failure, brain aneurysm, and chronic pain. Other symptoms include blood in urine, kidney stones, urinary tract or kidney infections, and back or side pain. It may develop over many years and lead to end-stage kidney (or renal) disease (ESRD). It has become a massive public health issue.
The global kidney disease market is expected to witness significant growth during the forecast period. As per the reports of the CDC, it is expected that more than 37 million people in the U.S. suffer from CKD, whereas globally, more than 500 million people are affected. An increasing number of patients suffering from kidney failure is projected to drive the market.
The investment made in the study would provide you access to information such as:
- Global Kidney Disease Market [Global – Broken-down into regions]
- Regional level split [North America, Europe, Asia Pacific, South America, Middle East & Africa]
- Country wise Market Size Split [of important countries with major market share]
- Market Share and Revenue/Sales by leading players
- Market Trends – Emerging Technologies/products/start-ups, PESTEL Analysis, SWOT Analysis, Porter’s Five Forces, etc.
- Market Size
- Market Size by application/industry verticals
- Market Projections/Forecast
Competitive Landscape
The research promotes high-end commercialization and profit-steering opportunities, and it takes market dimensions and volatility into account.
This section of the report also focuses on accurately decoding the competitive landscape with astute high-end identification of frontline players, complete with an in-depth analytical study of their business choices and investment discretion, to ensure thoroughly impeccable investor participation and noteworthy growth prospects.
To ensure a smooth ride and hopeful business returns despite numerous odds and unprecedented hurdles, this research has carefully gauged facts pertaining to portfolio advancements, geographical presence, and other essential market details.
The Kidney Disease Market is Dominated by Firms Such as
- Pfizer Inc (U.S.)
- AstraZeneca (U.K.)
- Bristol-Myers Squibb Company (U.S.)
- Allergan,Inc (Ireland)
- Dr. Reddy's Laboratories Ltd (India)
- Endo International plc (Ireland)
- Teva Pharmaceutical Industries Ltd (Israel)
- Sun Pharmaceutical Industries Ltd (India)
- Mylan N.V. (U.S.)
- Novartis AG (Switzerland)
- Lupin (India)
- Cipla Inc (India)
- Aurobindo Pharma (India)
- Fresenius SE & Co. KGaA (Germany)
- Sanofi (France)
- Takeda Pharmaceutical Company Limited (Japan)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Abbott (U.S.)
Download the Complete Research Study Here in PDF Format @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-kidney-disease-market
Recent Development
In October 2019, Fresenius Medical Care received breakthrough device designation by the U.S. FDA for its latest hemodialysis machine, which aims to stop blood clotting without using any medication.
Opportunities for Key Players:
- Increased Demands for Blood Tests
Among the major tests, the foremost test for the diagnosis of kidney disease includes a blood test, which helps understand how well the kidneys work. It measures levels of a waste product called creatinine in the blood. Furthermore, the demand for these tests is projected to increase as the incidence of CKD is high and growing in many parts of the world. The global incidence of end-stage renal disease (ESRD) is high and growing at a significant rate. Thus, it creates more opportunities for market growth.
- Increasing Demand for Hospitals
The presence of a large number of hospitals in the U.S., combined with a well-developed healthcare infrastructure, is another factor contributing to market growth. For instance, as per the American Hospital Association, there were around 208 federal government hospitals, 6,090 community hospitals, and 625 nonfederal psychiatric hospitals in the U.S. Major increase in the number of hospital admissions for acute kidney disease is boosting the demand for dialysis as well as transplant, thereby boosting the market growth.
Key Market Segments Covered in Kidney Disease Industry Research
By Indication
- Acute Kidney Injury
- Chronic Kidney Disease,
- End-Stage Renal Disease
By Treatment
- Medication
- Surgery
By Route of Administration
- Oral
- Parenteral
By End User
- Hospitals
- Homecare
- Specialty Clinics
By Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Key Industry Drivers:
- Increased Incidence of Kidney Diseases
The rising incidence of chronic kidney disease globally is majorly responsible for boosting the growth of the global renal drugs market. According to the National Kidney Foundation records, nearly 10% of the global population is affected by chronic kidney disease (CKD). As per WHO facts 2019, about 1.13 billion people worldwide have hypertension. In 2014–2016, diabetes and hypertension were responsible for around 75% of kidney failure. Thus, it boosts market growth.
- Technological Advancements
There have been many advances concerning diagnostic and treatment procedures that are boosting the market growth. For instance, in April 2020, FMCNA established the National Intensive Renal Care Reserve, which comprised devices that can deliver CRRT, IHD, and SLED/PIRRT. Any such conditions that cause reduced kidney function lead to chronic kidney disease (CKD), which may develop over a period and lead to end-stage renal kidney disease where the kidney can no longer function independently.
Browse Detailed Summary of Research Report @ https://www.databridgemarketresearch.com/reports/global-kidney-disease-market
Kidney Disease Market Regional Analysis/Insights:
The major countries covered in the kidney disease market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe has been witnessing the highest growth for the global kidney disease market throughout the forecasted period due to increasing initiatives by the government and pharmaceutical organizations to spread awareness and the presence of generic manufacturers.
North America dominates the market due to the advancement of technology for kidney diseases and increasing initiatives by pharmaceutical organizations to generate novel formulations.
It's in your best interest to take this report into consideration because:
- Strong and extensive research methods were used to construct this study. The thoroughness and precision of the market reports produced by Data Bridge Market Research have earned them a great reputation.
- A complete picture of the competitive scenario of Kidney Disease market is depicted by this report.
- The wide range of research on how these innovations may affect market expansion in the future.
- The report's findings are presented in an approachable format, with accompanying visuals (such as histograms, bar graphs, pie charts, etc.) that make the data readily digestible.
- The potential, threats, and difficulties in the Kidney Disease market, as well as the factors driving and restraining it, are discussed at length.
- It gives an all-encompassing evaluation of the anticipated conduct of the future market and the changing market condition.
- This kidney disease industry provides a number of strategic business approaches to assist you in making educated business decisions.
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Global Kidney Disease Market: Regulations
- Market Overview
- Global Kidney Disease Market, By Indication
- Global Kidney Disease Market, By Treatment
- Global Kidney Disease Market, By Route of Administration
- Global Kidney Disease Market, By End User
- Global Kidney Disease Market, By Distribution Channel
- Global Kidney Disease Market, By Region
- Global Kidney Disease Market: Company Landscape
- SWOT Analyses
- Company Profile
- Questionnaires
- Related Reports
Get the Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-kidney-disease-market
Explore More Reports:
- Chronic Kidney Disease (CKD) Market, By Product Type (Diagnosis, Treatment), Route of Administration (Oral, Intravenous, Subcutaneous), End Users (Hospitals, Diagnostic Laboratories, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-chronic-kidney-disease-ckd-market
- Polycystic Kidney Disease (PKD) Market, By Type (Autosomal Dominant Polycystic Kidney Disease, Autosomal Recessive Polycystic Kidney Disease, Others), Treatment (Medication, Surgery, Others), Diagnosis (Ultrasound, CT Scan, MRI Scan), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) https://www.databridgemarketresearch.com/reports/global-polycystic-kidney-disease-adpkd-market
- Kidney/Renal Function Test Market, By Product Type (Dipsticks, Reagents, Disposables), Test Type (Urine Tests, Blood Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-kidney-renal-function-test-market
- Kidney Stone Market, By Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy), Diagnosis (Ultrasound, Intravenous Pyelography, CT Scan, X-Ray, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-kidney-stone-market
- Kidney and Pancreas Transplant Market By Organ Type (Kidney, Pancreas), End- User (Hospitals, Transplant Centers, Others), Sources (Living Donors, Deceased Donors), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-kidney-pancreas-transplant-market
- Kidney Function Tests Market, By Test Type (Dilution and Concentration Tests, Clearance Tests, Urine Tests, Imaging Tests, Blood Test), Product Type (Dipsticks, Disposables, Reagents), End Use (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes) https://www.databridgemarketresearch.com/reports/global-kidney-function-tests-market
- Kidney Cancer Drugs Market, By Type (Renal Cell Carcinoma (RCC), Papillary Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Transitional Cell Carcinoma, Wilms Tumor (Nephroblastoma), Renal Sarcoma, Angiomyolipoma, Oncocytoma, Others), Drug Class (Monoclonal Antibodies, mTOR Inhibitors, Immune Checkpoint Inhibitor, Combined Therapies, Interleukin-2, Alpha-Interferon, Others), Drug Type (Branded, Generic), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country https://www.databridgemarketresearch.com/reports/global-kidney-cancer-drugs-market
- Artificial Kidney Market, By Device Type (Wearable Artificial Kidney, Implantable Artificial Kidney), Dialysis (Hemodialysis, Peritoneal Dialysis, Combination), Application (Adults, Pediatrics), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-artificial-kidney-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
